このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Bariatric Surgery in Children. (BASIC)

2021年8月25日 更新者:Maastricht University Medical Center

The BASIC Trial. Morbid Obesity in Children and Adolescents: a Prospective Randomised Trial of Conservative Treatment Versus Surgery

Rationale:

In the Western world overweight and obesity is an increasing problem both in adults and in children. In youth, it is associated with early death and a number of co-morbidities including metabolic and endocrine changes, increased inflammatory status, cardiovascular abnormalities, nonalcoholic fatty liver disease, and impaired quality of life.

The standard treatment for morbid obesity in children is by combined life style interventions. However, the medium and long term effects of dietetic interventions, behaviour therapy and medication is relatively poor. In adults bariatric surgery shows good results with up to 30% weight reduction in 3 years. The preliminary results in youth are similar, but surgery in this age group is relatively uncommon. In the Netherlands surgery in this age group is only allowed in clinical trials, until the benefits and risks have been established. (National Health Authorities)

Objective:

To determine if surgery gives a superior weight and body mass index (BMI) reduction than combined life style interventions in adolescents with morbid obesity and to assess its effect on obesity associated co-morbidity.

Study design:

Prospective randomised interventional study.

Study population:

Morbidly obese children, aged 14 - 16 years, with sex and age adjusted BMI >40 kg/m2 or >35 kg/m2 with co-morbidity.

Intervention:

Bariatric surgery by laparoscopic adjustable gastric band (LAGB) or combined life style interventions

Main study parameters/endpoints:

Primary endpoints: weight loss, loss of excess weight, loss of excess BMI. Secondary endpoints: Body composition, pubertal development, metabolic and endocrine changes, inflammatory status, cardiovascular abnormalities, non-alcoholic steatohepatitis, brain development, quality of life, and behaviour changes. The potential complications of surgery are monitored.

調査の概要

研究の種類

介入

入学 (実際)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Limburg
      • Maastricht、Limburg、オランダ、6202ZA
        • Maastricht University Medical Center

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

14年~16年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Aged 14 to 16
  • Age and sex adjusted BMI >40 kg/m2 or >35 kg/m2 with associated co-morbidity.

    * Associated co-morbidity includes: glucose intolerance, type 2 diabetes, hypertension, pseudotumor cerebri, acanthosis nigricans, obstructive sleep apnoea syndrome, depression, arthropathies, non-alcoholic steatohepatitis and dyslipidemia.

  • > 1 year multidisciplinary organized weight reducing attempts with less than 5% weight loss
  • Demonstrate decisional capacity

Exclusion Criteria:

  • Psychologically not suitable
  • Pre-menarche or bone age <15 years in boys
  • Obesity associated to other disorders such as hypothyroidism
  • Syndromal disorders such as Prader-Willi syndrome
  • Severe cardiorespiratory impairment (ASA class 3 or higher)
  • Insufficiently fluid in the Dutch language
  • Unwillingness to adhere to follow-up programmes

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:対照群
Control group will receive standard therapy consisting of combined lifestyle interventions.
実験的:Laparoscopic adjustable gastric band
Laparoscopic gastric band placement. Combined lifestyle interventions will continue after surgery.
Control group will receive standard therapy consisting of combined lifestyle interventions.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Weight
時間枠:6 months
Weight loss, excess weight loss and loss of excess BMI.
6 months
Weight
時間枠:12 months
Weight loss, excess weight loss and loss of excess BMI.
12 months
Weight
時間枠:24 months
Weight loss, excess weight loss and loss of excess BMI.
24 months
Weight
時間枠:36 months
Weight loss, excess weight loss and loss of excess BMI.
36 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Body composition
時間枠:12 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
12 months
Pubertal development
時間枠:6 months
Follow-up of hormonal status and Tanner stages.
6 months
Metabolic and endocrine changes
時間枠:6 months
6 months
Inflammatory status
時間枠:6 months
Measurement of serum inflammatory markers.
6 months
Cardiovascular abnormalities
時間枠:6 months
6 months
Non-alcoholic fatty liver disease
時間枠:6 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
6 months
Quality of life changes
時間枠:6 months
6 months
Behaviour changes
時間枠:6 months
Measuring impulsivity and positive reward dominance with a computer task.
6 months
Operative complications
時間枠:up to 36 months
Early and late complications are being monitored
up to 36 months
Effects on sleep architecture
時間枠:6 months
6 months
Brain development
時間枠:6 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
6 months
Body composition
時間枠:24 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
24 months
Body composition
時間枠:36 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
36 months
Pubertal development
時間枠:12 months
Follow-up of hormonal status and Tanner stages.
12 months
Pubertal development
時間枠:24 months
Follow-up of hormonal status and Tanner stages.
24 months
Pubertal development
時間枠:36 months
Follow-up of hormonal status and Tanner stages.
36 months
Metabolic and endocrine changes
時間枠:12 months
12 months
Metabolic and endocrine changes
時間枠:24 months
24 months
Metabolic and endocrine changes
時間枠:36 months
36 months
Inflammatory status
時間枠:12 months
Measurement of serum inflammatory markers.
12 months
Inflammatory status
時間枠:24 months
Measurement of serum inflammatory markers.
24 months
Inflammatory status
時間枠:36 months
Measurement of serum inflammatory markers.
36 months
Cardiovascular abnormalities
時間枠:12 months
12 months
Cardiovascular abnormalities
時間枠:24 months
24 months
Cardiovascular abnormalities
時間枠:36 months
36 months
Non-alcoholic fatty liver disease
時間枠:12 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
12 months
Non-alcoholic fatty liver disease
時間枠:24 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
24 months
Non-alcoholic fatty liver disease
時間枠:36 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
36 months
Quality of life changes
時間枠:12 months
12 months
Quality of life changes
時間枠:24 months
24 months
Quality of life changes
時間枠:36 months
36 months
Effects on sleep architecture
時間枠:12 months
12 months
Effects on sleep architecture
時間枠:24 months
24 months
Effects on sleep architecture
時間枠:36 months
36 months
Behaviour changes
時間枠:12 months
Measuring impulsivity and positive reward dominance with a computer task.
12 months
Behaviour changes
時間枠:24 months
Measuring impulsivity and positive reward dominance with a computer task.
24 months
Behaviour changes
時間枠:36 months
Measuring impulsivity and positive reward dominance with a computer task.
36 months
Brain development
時間枠:12 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
12 months
Brain development
時間枠:24 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
24 months
Brain development
時間枠:36 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
36 months
Physical activity
時間枠:6 months
Assessment of physical activity using a questionnaire and an accelerometer.
6 months
Physical activity
時間枠:12 months
Assessment of physical activity using a questionnaire and an accelerometer.
12 months
Physical activity
時間枠:24
Assessment of physical activity using a questionnaire and an accelerometer.
24
Physical activity
時間枠:36 months
Assessment of physical activity using a questionnaire and an accelerometer.
36 months
Behavior towards food
時間枠:6 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
6 months
Behavior towards food
時間枠:12 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
12 months
Behavior towards food
時間枠:24 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
24 months
Behavior towards food
時間枠:36 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
36 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:LWE van Heurn, Professor、Maastricht University Medical Center
  • 主任研究者:Yvonne Roebroek, PhD Student、Maastricht University Medical Center
  • 主任研究者:Givan F Paulus, PhD Student、Spaarne Gasthuis, Haarlem

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2011年12月1日

一次修了 (予想される)

2022年12月1日

研究の完了 (予想される)

2022年12月1日

試験登録日

最初に提出

2010年7月22日

QC基準を満たした最初の提出物

2010年7月29日

最初の投稿 (見積もり)

2010年7月30日

学習記録の更新

投稿された最後の更新 (実際)

2021年8月26日

QC基準を満たした最後の更新が送信されました

2021年8月25日

最終確認日

2021年8月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • NL26279.068.09

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する